世界のゲノムバイオマーカー市場2020-2027:用途別(腫瘍、心血管疾患、神経疾患、その他)、エンドユーザー別、地域別

◆英語タイトル:Global Genomic Biomarkers Market Size study, by Application (Oncology, Cardiovascular diseases, Neurological diseases, Others), by End-User (Diagnostic and research laboratories, Hospitals, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW20OC036
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年10月20日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査資料では、ゲノムバイオマーカーの世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、用途別(腫瘍、心血管疾患、神経疾患、その他)分析、エンドユーザー別(診断・研究所、病院、その他)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。

・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・ゲノムバイオマーカーの世界市場規模:用途別(腫瘍、心血管疾患、神経疾患、その他)
・ゲノムバイオマーカーの世界市場規模:エンドユーザー別(診断・研究所、病院、その他)
・ゲノムバイオマーカーの世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Genomic Biomarkers Market is valued approximately at USD 3.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2027. Genomic biomarkers possess the attribute of Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) that are typically used as a disease indicator, disease classification, and therapy assortment. They are minimally or non-invasive tools generally applied in imaging technology to deliver clear imaging of cancerous tumors & other complications, as well as reduce the possibilities of radiation treatment throughout CT scans and MRI scans. These biomarkers are further utilized to assess hyperkalemia, high blood pressure, and other monogenic circumstances. They reveal the function of gene, manifestation of a gene, and supervision of a gene in typical biologic procedures, pathogenic procedures, and responses to therapeutics.

The increase in the genomic biomarker market is significantly imputed to the fact that the technological advancements in genomic biomarker, such as Gene Expression Profiling (microarray) and Next-Generation Sequencing (NGS, is relentlessly expanding across the globe. Moreover, the rise in prevalence of chronic diseases such as cancer and cardiac disorder aligned with rising availability of funding for genomic biomarker research are the few other factors responsible for the CAGR of the market during the forecast period. According to the American Heart Association, CVD is the leading cause of death around the world. There were about 17.6 million deaths due to CVD registered in 2016, which is likely to grow almost 23.6 million by 2030. While there were around 17 million new cases of cancer and 9.5 million deaths were totaled in 2018 and is expecting to grow over 27.5 million new cancer cases and 16.3 million deaths by the year 2040. This, in turn, is expected to strengthen the market growth all over the world. However, the stringent government regulation coupled with the lack of standardization for validating the biomarker are the few factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Genomic Biomarkers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the supportive government policies and funding for genomic biomarker research along with the presence of a significant number of market vendors in the region. Whereas North America is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and cardiology diseases along with the presence of significant pharmaceutical and biotechnological infrastructure in the United States and Canada would create lucrative growth prospects for the Genomic Biomarkers market across the Asia-Pacific region.

Major market player included in this report are:
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Aepodia SA
Myriad Genetics Inc.
Eurofins Scientific
Qiagen
Bio-Rad Laboratories Inc.
Almac Group
Aros Applied Biotechnology A/S
Epigenomics AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Oncology
Cardiovascular diseases
Neurological diseases
Others

By End-User:
Diagnostic and research laboratories
Hospitals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Genomic Biomarkers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Genomic Biomarkers Market, by Region, 2018-2027 (USD Billion)
1.2.2. Genomic Biomarkers Market, by Application, 2018-2027 (USD Billion)
1.2.3. Genomic Biomarkers Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Genomic Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Genomic Biomarkers Market Dynamics
3.1. Genomic Biomarkers Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Genomic Biomarkers Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Genomic Biomarkers Market, by Application
5.1. Market Snapshot
5.2. Global Genomic Biomarkers Market by Application, Performance – Potential Analysis
5.3. Global Genomic Biomarkers Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
5.4. Genomic Biomarkers Market, Sub Segment Analysis
5.4.1. Oncology
5.4.2. Cardiovascular diseases
5.4.3. Neurological diseases
5.4.4. Others
Chapter 6. Global Genomic Biomarkers Market, by End-User
6.1. Market Snapshot
6.2. Global Genomic Biomarkers Market by End-User – Potential Analysis
6.3. Global Genomic Biomarkers Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Genomic Biomarkers Market, Sub Segment Analysis
6.4.1. Diagnostic and research laboratories
6.4.2. Hospitals
6.4.3. Others
Chapter 7. Global Genomic Biomarkers Market, Regional Analysis
7.1. Genomic Biomarkers Market, Regional Market Snapshot
7.2. North America Genomic Biomarkers Market
7.2.1. U.S. Genomic Biomarkers Market
7.2.1.1. Application breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Genomic Biomarkers Market
7.3. Europe Genomic Biomarkers Market Snapshot
7.3.1. U.K. Genomic Biomarkers Market
7.3.2. Germany Genomic Biomarkers Market
7.3.3. France Genomic Biomarkers Market
7.3.4. Spain Genomic Biomarkers Market
7.3.5. Italy Genomic Biomarkers Market
7.3.6. Rest of Europe Genomic Biomarkers Market
7.4. Asia-Pacific Genomic Biomarkers Market Snapshot
7.4.1. China Genomic Biomarkers Market
7.4.2. India Genomic Biomarkers Market
7.4.3. Japan Genomic Biomarkers Market
7.4.4. Australia Genomic Biomarkers Market
7.4.5. South Korea Genomic Biomarkers Market
7.4.6. Rest of Asia Pacific Genomic Biomarkers Market
7.5. Latin America Genomic Biomarkers Market Snapshot
7.5.1. Brazil Genomic Biomarkers Market
7.5.2. Mexico Genomic Biomarkers Market
7.6. Rest of The World Genomic Biomarkers Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Thermo Fisher Scientific Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. F. Hoffmann-La Roche Ltd.
8.2.3. Aepodia SA
8.2.4. Myriad Genetics Inc.
8.2.5. Eurofins Scientific
8.2.6. Qiagen
8.2.7. Bio-Rad Laboratories Inc.
8.2.8. Almac Group
8.2.9. Aros Applied Biotechnology A/S
8.2.10. EpiGenomic AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Genomic Biomarkers market, report scope
TABLE 2. Global Genomic Biomarkers market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Genomic Biomarkers market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 4. Global Genomic Biomarkers market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 5. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Genomic Biomarkers market
TABLE 76. List of primary sources, used in the study of global Genomic Biomarkers market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered

List of figures
FIG 1. Global Genomic Biomarkers market, research methodology
FIG 2. Global Genomic Biomarkers market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Genomic Biomarkers market, key trends 2019
FIG 5. Global Genomic Biomarkers market, growth prospects 2020-2027
FIG 6. Global Genomic Biomarkers market, porters 5 force Model
FIG 7. Global Genomic Biomarkers market, pest analysis
FIG 8. Global Genomic Biomarkers market, value chain analysis
FIG 9. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Genomic Biomarkers market, regional snapshot 2017 & 2027
FIG 18. North America Genomic Biomarkers market 2017 & 2027 (USD Billion)
FIG 19. Europe Genomic Biomarkers market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Genomic Biomarkers market 2017 & 2027 (USD Billion)
FIG 21. Latin America Genomic Biomarkers market 2017 & 2027 (USD Billion)
FIG 22. Global Genomic Biomarkers market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のゲノムバイオマーカー市場2020-2027:用途別(腫瘍、心血管疾患、神経疾患、その他)、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆